Europe — EMA
Absimky (Ustekinumab)
Absimky (Ustekinumab) is a subcutaneous medication used to manage moderate to severe plaque psoriasis. This biologic therapy targets specific proteins to help r
Request sourcing
What is Ustekinumab?
Absimky (Ustekinumab) is a subcutaneous medication used to manage moderate to severe plaque psoriasis. This biologic therapy targets specific proteins to help reduce inflammation and improve skin condition.
What is Ustekinumab used for?
Absimky is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy. It works by targeting specific proteins involved in the inflammatory process, helping to reduce the symptoms of psoriasis. People often ask, 'What is Absimky used for?' It is designed to provide relief for those who have not responded well to other treatments.
What are the side effects of Ustekinumab?
Common effects of Absimky may include redness, swelling, or itching at the injection site. Some users might experience headaches, fatigue, or upper respiratory infections. These effects vary and are not experienced by everyone.
What precautions apply to Ustekinumab?
Absimky should be handled with care. It is important to follow the prescribed administration guidelines and store the medication properly. Always consult a healthcare provider before starting or stopping any medication.
What does Ustekinumab interact with?
Absimky may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.



